KRAS activation has been reported to function as a master regulator, affecting the properties of multiple tumor microenvironment components and promoting cancer progression by mobilizing cells such as fibroblasts, macrophages, neutrophils, and lymphocytes [7, 9, 10]. This evidence concerns the gene KRAS and neoplasm.